Project Grant K99NS151037
- The National Institute of Neurological Disorders and Stroke, part of the Department of Health and Human Services National Institutes of Health, awarded $120,582 to President and Fellows of Harvard College on January 17, 2026, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853). The award funds research investigating motor learning mechanisms in cortico-basal ganglia circuits. The project explores how neural circuits generate behavioral...
- The National Institute of Neurological Disorders and Stroke, a component of the Department of Health and Human Services National Institutes of Health, awarded $120,582 to President and Fellows of Harvard College (operating as Harvard Medical School) on August 15, 2026, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853). The award funds research examining the functional specializations of cerebellar interneuron subtypes and their roles...
- The National Institute of Neurological Disorders and Stroke awarded President and Fellows of Harvard College $579,740 on June 1, 2026, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853). Harvard Medical School will conduct research to identify cell types and circuits that signal errors and their role in updating expectations for learning and cognitive flexibility. The work spans five years through March 31, 2031, performed in Boston,...
- The National Institute of Neurological Disorders and Stroke awarded the President and Fellows of Harvard College $636,084 on May 12, 2026, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853) to investigate structural, functional, and molecular remodeling of an adaptive sensorimotor circuit. The research uses C. elegans male mating behavior as a paradigm to understand experience-dependent plasticity across a sensorimotor circuit...
- The National Institute of Neurological Disorders and Stroke awarded President and Fellows of Harvard College $151,352 on August 27, 2026, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853) to investigate developmental activity and function of layer 5 cortical circuits following early postnatal reorganization. The research examines how inhibitory somatostatin-expressing cortical interneurons develop targeting specificity for distinct...
- The National Institute of Neurological Disorders and Stroke awarded Massachusetts Institute of Technology $651,069 on May 2, 2026, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853) to develop spatially multiplexed imaging techniques for visualizing complex signaling networks in neurons and brain cells. The research advances a method called Signaling Reporter Islands (SIRIs) that enables simultaneous imaging of multiple cellular signals...
- The National Institute of Neurological Disorders and Stroke awarded the President and Fellows of Harvard College $120,501 on February 2, 2026, to elucidate the molecular and functional diversity of dorsal root ganglia somatosensory neurons across mammals under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853). The research investigates how somatosensory neuron types, sensory receptors, and cell-type-specific physiology vary across mammalian...
- The National Institute of Neurological Disorders and Stroke awarded President and Fellows of Harvard College $595,961 on September 1, 2026, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853) to investigate mitochondrial DNA mutations and gene editing approaches in neural dysfunction. The research addresses mechanisms of central nervous system dysfunction triggered by mitochondrial DNA (mtDNA) mutations, particularly mutations in...
- The National Institute of Neurological Disorders and Stroke (NINDS), part of the Department of Health and Human Services National Institutes of Health, awarded $153,560 to the Broad Institute, Inc. (doing business as Broad Institute of MIT and Harvard) on December 1, 2026, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853). The award funds research examining how excitatory neurons regulate interneuron fate, position, and survival during...
- The National Institute of Neurological Disorders and Stroke, a component of the Department of Health and Human Services National Institutes of Health, awarded Massachusetts Institute of Technology $436,242 on July 1, 2026, under the Child Health and Human Development Extramural Research program (CFDA 93.865) to support predoctoral training in neuroscience and cognitive science. MIT's Department of Brain and Cognitive Sciences will deliver interdisciplinary graduate training spanning cellular and...
The National Institute of Neurological Disorders and Stroke awarded $104,288 to President and Fellows of Harvard College on August 15, 2026, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853). Harvard's Office for Sponsored Programs will develop a high-throughput molecular connectomics tool with synaptic resolution to map the molecular basis of synapse formation and specification. The work integrates neuronal wiring diagrams with molecular data such as gene expression to clarify relationships between molecules and synaptic specification across different neural circuits. The project will generate hypotheses for the molecular basis of synapse formation and integrate pooled perturbations to conduct large-scale mechanistic discovery of novel functional synaptic molecules. Performance occurs in Cambridge, Massachusetts, with a period of performance from award date through July 31, 2028. This project grant supports basic research exploring fundamental structure and function of the brain and nervous system, aligned with NINDS's mission to reduce the burden of neurological disease.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $104.3k | 8/11/26 |